Evidence map›Paper›PMID 28977738›Full record

ArticleChemMedChem2017

Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation.

Vincent Wagner, Linda Jantz, Hans Briem, Kai Sommer, Matthias Rarey, Clara D Christ

Abstract read
In one paragraph

Article in ChemMedChem, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Best Practices for Alchemical Free Energy Calculations [Article v1.0].Living journal of computational molecular science · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincent WagnerBayer AG, Drug Discovery, Medicinal Chemistry, 13353, Berlin, Germany.
Linda JantzUniversität Hamburg, ZBH-Center for Bioinformatics, 20146, Hamburg, Germany.
Hans BriemBayer AG, Drug Discovery, Medicinal Chemistry, 13353, Berlin, Germany.
Kai SommerUniversität Hamburg, ZBH-Center for Bioinformatics, 20146, Hamburg, Germany.ORCID 0000-0003-1866-8247
Matthias RareyUniversität Hamburg, ZBH-Center for Bioinformatics, 20146, Hamburg, Germany.ORCID 0000-0002-9553-6531
Clara D ChristBayer AG, Drug Discovery, Medicinal Chemistry, 13353, Berlin, Germany.ORCID 0000-0002-5424-9819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocycles play an increasing role in drug discovery, but their synthesis is often demanding. Computational tools that suggest macrocyclization based on a known binding mode and that estimate the binding affinity of these macrocycles could have a substantial impact on the medicinal chemistry design process. For both tasks, we established a workflow with high practical value. For five diverse pharmaceutical targets we show that the effect of macrocyclization on binding can be calculated robustly and accurately. Applying this method to macrocycles designed by LigMac, a search tool for de novo macrocyclization, our results suggest that we have a robust protocol in hand to design macrocycles and prioritize them prior to synthesis.

Indexed as

Macrocyclic CompoundsMolecular StructureMacrocyclic Compoundsdrug designfree energy calculationsmacrocyclesmolecular dynamicsmolecular modeling

Identifiers

PMID28977738
PMCPMC5725703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.